HII Celebrates 170 Graduates of The Apprentice School at Newport News Shipbuilding Ceremony

Written by Customer Service on March 12, 2022. Posted in Public Companies.

2022 Apprentice School at Newport News Shipbuilding Commencement Chris Rose (Homer L. Ferguson Award Recipient) speaks during the 2022 Apprentice School at Newport News Shipbuilding Commencement Ceremony. NEWPORT NEWS, Va., March 12, 2022 (GLOBE NEWSWIRE) — Global engineering and defense technologies provider HII (NYSE:HII) hosted commencement exercises today for 170 graduates of the company’s Apprentice School at Newport News Shipbuilding (NNS). The ceremony was held at Liberty Live Church in Hampton. Newport News Shipbuilding President Jennifer Boykin began the event by addressing the graduates as the shipyard’s newest leaders. “I want you to know how proud I am of each of you for everything that you’ve accomplished,” Boykin said. “Today is just the next step towards your leadership role at Newport News Shipbuilding,...

VÍS: Framboð til stjórnar og tilnefningarnefndar VÍS vegna aðalfundar 2022

Written by Customer Service on March 12, 2022. Posted in Public Companies.

Aðalfundur Vátryggingafélags Íslands hf. verður haldinn fimmtudaginn 17. mars 2022 kl. 16:00 í höfuðstöðvum félagsins, Ármúla 3, 108 Reykjavík, auk þess sem gefinn er kostur á rafrænni þátttöku á fundinum. Framboðsfrestur vegna stjórnar og tilnefningarnefndar Vátryggingafélag Íslands hf. rann út þann 12. mars 2022 kl. 16:00. Meðfylgjandi eru upplýsingar um þá aðila sem gefið hafa kost á sér til setu í stjórn og varastjórn annars vegar, og í tilnefninganefnd hins vegar. Er það mat stjórnar að öll framboð séu gild sbr. 63. gr. a. hlutafélagalaga nr. 2/1995. Þar sem fimm einstaklingar hafa boðið sig fram til aðalstjórnar, tveir til varastjórnar og þrír einstaklingar hafa boðið sig fram til setu í tilnefningarnefnd er ljóst að sjálfkjörið er í stjórn og tilnefningarnefnd. Önnur fundargögn tengd hluthafafundi má nálgast á vef félagsins: https://vis.is/hluthafafundir/. ...

Osisko Green Acquisition Limited Reports 2021 Financial Results

Written by Customer Service on March 12, 2022. Posted in Public Companies.

TORONTO, March 11, 2022 (GLOBE NEWSWIRE) — Osisko Green Acquisition Limited (TSX:GOGR) (the “Corporation”) is reporting its financial results as at December 31, 2021 and for the period from inception of the Corporation on July 8, 2021 to December 31, 2021. The Corporation is also announcing that there are no material updates regarding its search for target businesses with which it may complete its qualifying acquisition. The Corporation’s audited annual financial statements, along with the accompanying management’s discussion and analysis have been filed on the System for Electronic Document Analysis and Retrieval (“SEDAR”) and may be viewed by interested parties under the Corporation’s profile at www.sedar.com or the Corporation’s website at www.osiskogreen.com. About Osisko Green Acquisition Limited The Corporation is a special...

Liquid Media Announces Issuance of Cease Trade Order by the British Columbia Securities Commission to Investors Residing In British Columbia, Canada

Written by Customer Service on March 12, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) discloses the issuance of a cease trade order (“CTO”) by the British Columbia Securities Commission (“BCSC”) under National Instrument 51-102 – Continuous Disclosure Obligations effective March 9, 2022, as a result of the Company not having filed its audited annual financial statements, accompanying management’s discussion and analysis and annual information form for the financial year ended November 30, 2021 (together, the “Annual Filings”). As previously announced on March 4, 2022, the Company has experienced unexpected delays in consolidating financial information from, and completing purchase accounting for its recently acquired operations. However, the Company is actively and expeditiously...

Global Care Capital Announces Closing of Initial Tranche Pursuant to Investor Agreement

Written by Customer Service on March 12, 2022. Posted in Public Companies.

NOT FOR RELEASE TO US WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V2) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce the initial closing under the convertible securities purchase agreement, the details of which are described in the Company’s release of February 25, 2022 and the issuance of an unsecured zero-coupon convertible securities with a principal amount of US$744,000 for a purchase price of US$600,000 and 6,339,872 shares in satisfaction of a fee payable to the investor at a deemed price of $0.05 per Share. All the securities issued under the initial closing are subject to a statutory...

Reservoir Capital Corp. Update on Nigerian Dispute

Written by Customer Service on March 12, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) — (CSE: REO) – Reservoir Capital Corp. (“REO” or the “Company“) would like to provide an update on the ongoing dispute with a Nigerian shareholder (see the news release filed on the Company’s SEDAR profile on May 7, 2021 for further details on the dispute and related litigation). As a result of this dispute, the Company has suffered partial payment of dividends from Nigerian hydro company Mainstream Energy Solutions Ltd (“MESL”) from late 2020 until the present. Of the Company’s $4,850,621 in combined dividend income in 2020 and 2021, $2,450,600 has been withheld and accrued as a result of the dispute. The Company has received assurance from representatives of the disputing Nigerian shareholder that (i) litigation filed in Nigerian...

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

Written by Customer Service on March 12, 2022. Posted in Public Companies.

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer SALT LAKE CITY, March 11, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the U.S. Food and Drug Administration (FDA) has approved Myriad’s BRACAnalysis® CDx test for use as a companion diagnostic to identify patients with germline BRCA-mutated (gRBCAm) HER2 negative, high-risk early-stage breast cancer who may benefit from Lynparza®(olaparib). “This most recent regulatory approval confirms the benefits of using biomarkers to help guide care for patients with breast cancer,” said Nicole Lambert, chief operating officer, Myriad Genetics. “Data from the OlympiA trial and numerous other clinical...

Day: March 12, 2022